Home > Drug Search >
  • company_query: Apexigen
  •   > 
Drug Filter
Category:
chemistry (11) biology (32)
Status:
Approved (5) NDA Filing (1) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (15) Phase Ⅰ (13) IND Filing (4)
Clinical Stage:
Pending (3) Active (32) Discontinued (3)
Bio-Type:
Coagulation factor (2) CAR T cell therapy (1) Vaccine (10) Microbial extract (2) Recombinant cytokines (3) Whole antibody (4)
Indication:
Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Diabetic macular edema (1) Endometriosis (1) Transplant rejection (1) Epidermolysis bullosa (1) Follicular lymphoma (1) Hypertension (1) Blepharospasm (1) Glabellar line (2) Influenza virus infection (7) Leukemia (1) Lymphoma (1) Graves ophthalmopathy (1) Mantle cell lymphoma (MCL) (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Obesity (1) Ovarian cancer (1) Post-polycythemia vera (1) Prostate cancer (1) Psoriasis (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Type 2 diabetes (3) Chronic heart failure (1) Neuroblastoma (1) Pain (1) Cervical carcinoma (1) Waldenström's macroglobulinemia (WM) (1) B-cell lymphoma (1) Sickle cell disease (1) Hemophilia B (1) Neutropenia (2) Condylomata acuminata (1) Contraception (1) Hypertrophic cardiomyopathy (1) Respiratory syncytial virus infection (1) Diffuse large B cell lymphoma (1) Ebola virus disease (EVD) (1) Acquired thrombotic thrombocytopenic purpura (1) Human papillomavirus infections (HPV) (2) Blood coagulation disorders (1) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top